Nalaganje...
Management of Treatment‐Related Adverse Events with Agents Targeting the MAPK Pathway in Patients with Metastatic Melanoma
Tremendous progress has been made in the clinical landscape of advanced‐stage BRAF V600–mutant melanoma treatment over the past 5 years. Targeted therapies that inhibit specific steps of the mitogen‐activated protein kinase pathway have been shown to provide significant overall treatment benefit in...
Shranjeno v:
| izdano v: | Oncologist |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
AlphaMed Press
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5507648/ https://ncbi.nlm.nih.gov/pubmed/28526719 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0456 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|